Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ardelyx Inc (NQ: ARDX )

3.980 +0.050 (+1.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ardelyx Inc

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
41 Stocks Moving In Friday's Mid-Day Session
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares jumped 90.6% to $7.84 after the company said the FDA has granted its eryaspase fast track designation for the treatment of acute... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Erytech Pharma (NASDAQ:ERYP) shares moved upwards by 79.56% to $7.38 during Friday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
Ardelyx's Tenapanor Application For Chronic Kidney Disease Receives FDA Response Letter
The FDA has issued a Complete Response Letter (CRL) to Ardelyx Inc's (NASDAQ: ARDX) marketing application seeking approval for tenapanor to control serum... 
Via Benzinga
Exposures Product Safety
20 Stocks Moving in Friday's Pre-Market Session
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 50.9% to $6.20 in pre-market trading after the company announced its eryaspase was granted U.S. FDA Fast Track designation... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Erytech Pharma (NASDAQ:ERYP) sha... 
Via Benzinga
REMINDER: Scott+Scott Attorneys at Law LLP Continues its Investigation into Ardelyx Inc. (ARDX)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... 
Via Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs, And More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefited from the optimism that was set in motion by the solid start to the pharma reporting... 
Via Talk Markets
Exposures Product Safety
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (... 
Via Benzinga
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Ardelyx Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Ardelyx, Inc.
From Kirby McInerney LLP
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Chembio Diagnostics (NASDAQ: CEMI) shares rose 102.91% to $4.18 during Wednesday's pre-market session. The market value of their outstanding shares is at $84.6 million.... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
SVB Leerink boosted Intuitive Surgical, Inc. (NASDAQ: ISRG) price target from $930 to $975. Intuitive Surgical shares gained 3.8% to $991.17 in pre-market trading. Rosenblatt... 
Via Benzinga
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,... 
Via Benzinga
Scott+Scott Attorneys at Law LLP Announces Investigation into Ardelyx Inc. (ARDX)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
62 Biggest Movers From Yesterday
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment... 
Via Benzinga
Exposures Product Safety
Why Ardelyx Shares Tanked Today
Ardelyx (NASDAQ: ARDX) shares are trading lower after the company received an FDA letter regarding its NDA for tenapanor indicating deficiencies that preclude discussion of... 
Via Benzinga
Exposures Product Safety
Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded up 1.83% to 34,583.56 while the NASDAQ rose 1.74% to 14,523.41. The S&P also rose, gaining 1.70% to 4,330.82. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NeuroMetrix (NASDAQ:NURO) shares moved upwards by 177.6% to $9.05 during Tuesday's regular session. As of 12:30 EST, NeuroMetrix's stock is trading at a... 
Via Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550. NeuroMetrix, Inc. (NASDAQ: NURO) gained 37.4% to $4.4750 as the company said it received FDA... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; Philip Morris Posts Mixed Q2 Results
Following the market opening Tuesday, the Dow traded up 1.32% to 34,409.28 while the NASDAQ rose 0.48% to 14,343.85. The S&P also rose, gaining 0.91% to 4,297.39. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
ARDX Stock: Disastrous FDA News Sends Ardelyx Shares Plummeting
News from the FDA is not good for ARDX stock. Investor reaction has been swift and harsh, as is often the case with risky biotech stocks. 
Via InvestorPlace
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021
Upgrades For Bank of Marin Bancorp (NASDAQ: 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET Tuesday, 64 stocks made new 52-week lows. Key Facts: TotalEnergies (NYSE:TTE) was the largest, in terms of market cap, to set a new 52-week low.... 
Via Benzinga
Why Ardelyx Stock Is Getting Crushed Today
The FDA doesn't appear to be impressed by the biotech's experimental kidney disease drug. 
Via The Motley Fool
Exposures Product Safety
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock moved upwards by 36.87% to $3.86 during Tuesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares rose 36.9% to $3.86 in pre-market trading after gaining more than 3% on Monday. SuperCom Ltd. (NASDAQ: SPCB) shares... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.